530313 Stock Overview
Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Kimia Biosciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹51.60 |
| 52 Week High | ₹58.40 |
| 52 Week Low | ₹31.99 |
| Beta | 0.99 |
| 1 Month Change | -4.90% |
| 3 Month Change | 41.41% |
| 1 Year Change | 46.38% |
| 3 Year Change | 17.41% |
| 5 Year Change | 51.10% |
| Change since IPO | 454.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| 530313 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -4.3% | 1.4% | 2.8% |
| 1Y | 46.4% | 57.2% | 46.6% |
Return vs Industry: 530313 underperformed the Indian Pharmaceuticals industry which returned 57.2% over the past year.
Return vs Market: 530313 matched the Indian Market which returned 46.6% over the past year.
Price Volatility
| 530313 volatility | |
|---|---|
| 530313 Average Weekly Movement | 11.5% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 530313's share price has been volatile over the past 3 months.
Volatility Over Time: 530313's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 241 | Sameer Goel | www.kimiabiosciences.com |
Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients in India. It exports its products. The company was formerly known as Laurel Organics Ltd and changed its name to Kimia Biosciences Limited January 2019.
Kimia Biosciences Limited Fundamentals Summary
| 530313 fundamental statistics | |
|---|---|
| Market cap | ₹2.44b |
| Earnings (TTM) | -₹132.69m |
| Revenue (TTM) | ₹972.38m |
2.5x
P/S Ratio-18.4x
P/E RatioIs 530313 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 530313 income statement (TTM) | |
|---|---|
| Revenue | ₹972.38m |
| Cost of Revenue | ₹754.56m |
| Gross Profit | ₹217.82m |
| Other Expenses | ₹350.51m |
| Earnings | -₹132.69m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 14, 2024
| Earnings per share (EPS) | -2.80 |
| Gross Margin | 22.40% |
| Net Profit Margin | -13.65% |
| Debt/Equity Ratio | 14,872.7% |
How did 530313 perform over the long term?
See historical performance and comparison